In this prospective cohort study, the researchers observed an association between maternal depressive symptoms during pregnancy with slower rates of fetal growth.
Maternal depression during the third trimester, not prenatal SSRI exposure, was associated with higher levels of internalizing and anxiety behaviors in children from 3 to 12 years of age.
Should we also be assessing women’s partners to determine if they have postpartum depression?
Fetal brain development is altered by elevated maternal distress and has adverse infant social-emotional and cognitive outcomes.
Some studies have demonstrated associations between in utero exposure to antidepressants and cognitive outcomes.
Neuroimaging studies indicate that exposure to antenatal depression may determine risk for later neuropsychiatric illness in the child.
There have been multiple studies over last year showing increased anxiety and depression in certain populations as a result of the COVID pandemic. It is clear that some members of the population may be [...]
The COVID-19 pandemic has impacted the way antenatal care is being delivered in the United States, such as having fewer visits and replacing some in-clinic visits with virtual visits over telemedicine platforms. There has been [...]
In a given year, about 10% of mothers in the United States experience a major depressive episode (MDE). Roughly translated, this means about 1 in 10 children is exposed to maternal depression each year (Ertel [...]
When a woman comes in for a consultation regarding the use of medications during pregnancy, we spend most of our time reviewing the potential risks of exposure to medications during pregnancy. However, we must also [...]
